{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:40:52Z","timestamp":1778035252746,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["R269-A15989"],"award-info":[{"award-number":["R269-A15989"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.radonc.2025.110906","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:43:23Z","timestamp":1746337403000},"page":"110906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial"],"prefix":"10.1016","volume":"207","author":[{"given":"Anna Mann","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2964-4347","authenticated-orcid":false,"given":"Michael R.T.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-4495","authenticated-orcid":false,"given":"Laura A.","family":"Rechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-8011","authenticated-orcid":false,"given":"Sebastian Moretto","family":"Krog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-3533","authenticated-orcid":false,"given":"Katrine S","family":"Storm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-0007","authenticated-orcid":false,"given":"Wiviann","family":"Ottosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja R","family":"Gram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-2766","authenticated-orcid":false,"given":"Morten H.","family":"Suppli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan R.","family":"Vogelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-7777","authenticated-orcid":false,"given":"Claus P.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3363-3256","authenticated-orcid":false,"given":"Gitte","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110906_b0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(08)70089-9","article-title":"Metastatic epidural spinal cord compression","volume":"7","author":"Cole","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.radonc.2025.110906_b0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2022.06.002","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases","volume":"173","author":"Oldenburger","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.prro.2024.04.018","article-title":"External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline","volume":"14","author":"Alcorn","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2019.11.008","article-title":"Patient reported upper gastro-intestinal symptoms associated with fractionated image-guided conformal radiotherapy for metastatic spinal cord compression","volume":"13","author":"Gram","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41416-020-0768-z","article-title":"Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression","volume":"122","author":"Thirion","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2025.110906_b0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.2015.64.0862","article-title":"Radiotherapy With 4 Gy \u00d7 5 Versus 3 Gy \u00d7 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009\/01)","volume":"34","author":"Rades","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10330-011-0832-5","article-title":"Single-versus multi-fraction radiation treatment for metastatic spinal cord compression: functional outcome study","volume":"10","author":"Abu-Hegazy","year":"2011","journal-title":"Chin-Ger J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0040","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2005.08.193","article-title":"Short-course versus split-course radiotherapy in metastatic spinal cord compression: Results of a phase III, randomized, multicenter trial","volume":"23","author":"Maranzano","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2009.05.012","article-title":"8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: Results of a phase III randomized multicentre Italian trial","volume":"93","author":"Maranzano","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0050","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2019.17913","article-title":"Effect of single-fraction vs multifraction radiotherapy on ambulatory status among patients with spinal canal compression from metastatic cancer: the SCORAD randomized clinical trial","volume":"322","author":"Hoskin","year":"2019","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.110906_b0055","doi-asserted-by":"crossref","unstructured":"Rades D, Cacicedo J, Conde-Moreno AJ, et al. Precision radiation therapy for metastatic spinal cord compression: final results of the PRE-MODE trial. Int J Radiation Oncol Biol Phys. 106(4):2020. doi:10.1016\/j.ijrobp.2019.11.401.","DOI":"10.1016\/j.ijrobp.2019.11.401"},{"key":"10.1016\/j.radonc.2025.110906_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.7664","article-title":"Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial","volume":"8","author":"Louie","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2018.02.028","article-title":"Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer","volume":"127","author":"McDermott","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tipsro.2022.07.001","article-title":"Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study","volume":"23","author":"Gram","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0075","doi-asserted-by":"crossref","unstructured":"Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30(19):2186-2191. doi:10.1097\/01.BRS.0000180401.06919.A5.","DOI":"10.1097\/01.brs.0000180401.06919.a5"},{"key":"10.1016\/j.radonc.2025.110906_b0080","unstructured":"Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Accessed February 11, 2025. https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/."},{"key":"10.1016\/j.radonc.2025.110906_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.110906_b0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.radonc.2025.110906_b0095","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/0284186X.2023.2251083","article-title":"Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy","volume":"62","author":"Nielsen","year":"2023","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2025.110906_b0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Phase II randomised trial Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/cancers16061149","article-title":"Radiotherapy for metastatic epidural spinal cord compression with increased doses: final results of the RAMSES-01 trial","volume":"16","author":"Rades","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.110906_b0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/17407745221093935","article-title":"Timing is everything: the importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events","volume":"19","author":"King-Kallimanis","year":"2022","journal-title":"Clin Trials"},{"key":"10.1016\/j.radonc.2025.110906_b0115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncr.20756","article-title":"Prediction of survival in patients with metastases in the spinal column","volume":"103","author":"Van Der Linden","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110906_b0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00066-018-1333-z","article-title":"Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial): First results of a randomized controlled trial","volume":"194","author":"Sprave","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110906_b0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jclinepi.2015.12.003","article-title":"Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses","volume":"74","author":"Hussain","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2025.110906_b0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2020.04.045","article-title":"The use of patient reported outcome measures (PROMs) in palliative radiotherapy: a topical review","volume":"149","author":"Oldenburger","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110906_b0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnci\/djae039","article-title":"Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial","volume":"116","author":"Hoskin","year":"2024","journal-title":"JNCI: J Nat Cancer Inst"},{"key":"10.1016\/j.radonc.2025.110906_b0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SPC.0000000000000644","article-title":"Patient-reported outcomes versus proxy-reported outcomes in supportive and palliative care: a summary of recent literature","volume":"17","author":"Oldenburger","year":"2023","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.radonc.2025.110906_b0150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:41:26Z","timestamp":1762256486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S0167814025002014"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110906","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110906"}}